IDEAS home Printed from https://ideas.repec.org/a/gam/jsusta/v10y2018i9p3143-d167486.html
   My bibliography  Save this article

Factors Affecting Pricing in Patent Licensing Contracts in the Biopharmaceutical Industry

Author

Listed:
  • Jeong Hee Lee

    (Graduate School of Health Science Business Convergence, College of Medicine, Chungbuk National University, Cheongju 28644, Korea)

  • Eungdo Kim

    (Graduate School of Health Science Business Convergence, College of Medicine, Chungbuk National University, Cheongju 28644, Korea)

  • Tae-Eung Sung

    (Department of Computer and Telecommunications Engineering, College of Science and Technology, Yonsei University, 1 Yonseidae-gil, Wonju 26493, Gangwon-do, Korea)

  • Kwangsoo Shin

    (Graduate School of Health Science Business Convergence, College of Medicine, Chungbuk National University, Cheongju 28644, Korea)

Abstract

This paper analyzes factors affecting pricing in patent licensing contracts in the biopharmaceutical industry based on a dataset that includes royalty-related data such as running royalty rate, up-front payment, milestones, and deal value. Data on drug candidates for 11 drug classes is obtained for regression analysis between royalty-related data and multiple input descriptors such as market factors, licensor factors, and licensee factor in order to derive the formula for predicting royalty-related estimates such as royalty rate, up-front payment, milestones, and deal value. Data is gathered from multiple sources including MedTrack and is processed through merging and cleaning. We found that the three most important factors in pricing in patent licensing in the biopharmaceutical industry are CAGR (Compound Annual Growth Rate), PDELR (Previous Deal Experience of Licensor), and AR (Attrition Rate). We found that factors in the formula used to estimate the license fee are totally different by drug class. We found that the three most important factors in the frequency in the formula used to estimate the license fee are PDELR, RnDLR (R&D Costs of Licensor), and PDELE (Previous Deal Experience of Licensee). This study suggests a method of estimating the proper royalty rate, up-front payment, milestones, and deal value of the drug candidates of 11 drug classes by using easily obtained input data.

Suggested Citation

  • Jeong Hee Lee & Eungdo Kim & Tae-Eung Sung & Kwangsoo Shin, 2018. "Factors Affecting Pricing in Patent Licensing Contracts in the Biopharmaceutical Industry," Sustainability, MDPI, vol. 10(9), pages 1-21, September.
    • Handle: RePEc:gam:jsusta:v:10:y:2018:i:9:p:3143-:d:167486
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2071-1050/10/9/3143/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2071-1050/10/9/3143/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Bharat N. Anand & Tarun Khanna, 2000. "The Structure of Licensing Contracts," Journal of Industrial Economics, Wiley Blackwell, vol. 48(1), pages 103-135, March.
    2. Scott Shane, 2002. "Selling University Technology: Patterns from MIT," Management Science, INFORMS, vol. 48(1), pages 122-137, January.
    3. repec:bla:jindec:v:48:y:2000:i:1:p:103-35 is not listed on IDEAS
    4. Harhoff, Dietmar & Scherer, Frederic M. & Vopel, Katrin, 2003. "Citations, family size, opposition and the value of patent rights," Research Policy, Elsevier, vol. 32(8), pages 1343-1363, September.
    5. Jean Olson Lanjouw, 1998. "Patent Protection in the Shadow of Infringement: Simulation Estimations of Patent Value," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 65(4), pages 671-710.
    6. Harhoff, Dietmar & Gambardella, Alfonso & Verspagen, Bart, 2008. "The Value of European Patents," CEPR Discussion Papers 6848, C.E.P.R. Discussion Papers.
    7. Mariko Sakakibara, 2010. "An empirical analysis of pricing in patent licensing contracts," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(3), pages 927-945, June.
    8. Xuan Nguyen & Pasquale Sgro & Munirul Nabin, 2017. "Optimal Licensing Policy under Vertical Product Differentiation," Review of Development Economics, Wiley Blackwell, vol. 21(3), pages 497-510, August.
    9. Boris Bogdan & Ralph Villiger, 2010. "Valuation in Life Sciences," Springer Books, Springer, number 978-3-642-10820-4, January.
    10. Nancy T. Gallini & Ralph A. Winter, 1985. "Licensing in the Theory of Innovation," RAND Journal of Economics, The RAND Corporation, vol. 16(2), pages 237-252, Summer.
    11. Mark Schankerman, 1998. "How Valuable is Patent Protection? Estimates by Technology Field," RAND Journal of Economics, The RAND Corporation, vol. 29(1), pages 77-107, Spring.
    12. Andrea Shepard, 1987. "Licensing to Enhance Demand for New Technologies," RAND Journal of Economics, The RAND Corporation, vol. 18(3), pages 360-368, Autumn.
    13. Bessy, Christian & Brousseau, Eric, 1998. "Technology licensing contracts features and diversity1," International Review of Law and Economics, Elsevier, vol. 18(4), pages 451-489, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Chien-Shu Tsai & Ting-Chung Tsai & Po-Sheng Ko & Chien-Hui Lee & Jen-Yao Lee & Yu-Lin Wang, 2019. "On the Sustainability of Technology Licensing Under Asymmetric Information Game," Sustainability, MDPI, vol. 11(24), pages 1-15, December.
    2. Eungdo Kim & InGyu Lee & Hongbum Kim & Kwangsoo Shin, 2021. "Factors Affecting Outbound Open Innovation Performance in Bio-Pharmaceutical Industry-Focus on Out-Licensing Deals," Sustainability, MDPI, vol. 13(8), pages 1-17, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Federico Munari & Maurizio Sobrero, 2011. "Economic and Management Perspectives on the Value of Patents," Chapters, in: Federico Munari & Raffaele Oriani (ed.), The Economic Valuation of Patents, chapter 3, Edward Elgar Publishing.
    2. Maria Isabella Leone & Raffaele Oriani & Toke Reichstein, 2015. "How much are flexibility and uncertainty worth in patent licensing?," Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 42(4), pages 371-394, December.
    3. Carlos J. Serrano, 2010. "The dynamics of the transfer and renewal of patents," RAND Journal of Economics, RAND Corporation, vol. 41(4), pages 686-708, December.
    4. Elizabeth Webster & Paul H. Jensen, 2011. "Do Patents Matter for Commercialization?," Journal of Law and Economics, University of Chicago Press, vol. 54(2), pages 431-453.
    5. Bessen, James, 2009. "Estimates of patent rents from firm market value," Research Policy, Elsevier, vol. 38(10), pages 1604-1616, December.
    6. Preet S Aulakh & Marshall S Jiang & Yigang Pan, 2010. "International technology licensing: Monopoly rents, transaction costs and exclusive rights," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 41(4), pages 587-605, May.
    7. Appio, Francesco Paolo & Baglieri, Daniela & Cesaroni, Fabrizio & Spicuzza, Lucia & Donato, Alessia, 2022. "Patent design strategies: Empirical evidence from European patents," Technological Forecasting and Social Change, Elsevier, vol. 181(C).
    8. Grönqvist, Charlotta, 2009. "Empirical studies on the private value of Finnish patents," Bank of Finland Scientific Monographs, Bank of Finland, volume 0, number sm2009_041, July.
    9. Bruno Pottelsberghe de la Potterie & Nicolas Zeebroeck, 2008. "A brief history of space and time: The scope-year index as a patent value indicator based on families and renewals," Scientometrics, Springer;Akadémiai Kiadó, vol. 75(2), pages 319-338, May.
    10. Nancy Gallini & Suzanne Scotchmer, 2002. "Intellectual Property: When Is It the Best Incentive System?," NBER Chapters, in: Innovation Policy and the Economy, Volume 2, pages 51-78, National Bureau of Economic Research, Inc.
    11. Shen, Huijun & Coreynen, Wim & Huang, Can, 2023. "Prestige and technology-transaction prices: Evidence from patent-selling by Chinese universities," Technovation, Elsevier, vol. 123(C).
    12. Harhoff, Dietmar & van Pottelsberghe de la Potterie, Bruno & Hoisl, Karin, 2009. "Languages, Fees and the International Scope of Patenting," CEPR Discussion Papers 7241, C.E.P.R. Discussion Papers.
    13. Jean O. Lanjouw & Mark Schankerman, 1999. "The Quality of Ideas: Measuring Innovation with Multiple Indicators," NBER Working Papers 7345, National Bureau of Economic Research, Inc.
    14. Zhang, Gupeng & Lv, Xiaofeng & Zhou, Jianghua, 2014. "Private value of patent right and patent infringement: An empirical study based on patent renewal data of China," China Economic Review, Elsevier, vol. 28(C), pages 37-54.
    15. Torben Schubert, 2011. "Assessing the value of patent portfolios: an international country comparison," Scientometrics, Springer;Akadémiai Kiadó, vol. 88(3), pages 787-804, September.
    16. Cesare Righi & Davide Cannito & Theodor Vladasel, 2023. "Continuing Patent Applications at the USPTO," Working Papers 1382, Barcelona School of Economics.
    17. Gupeng, Zhang & Xiangdong, Chen, 2012. "The value of invention patents in China: Country origin and technology field differences," China Economic Review, Elsevier, vol. 23(2), pages 357-370.
    18. Gambardella, Alfonso, 2013. "The economic value of patented inventions: Thoughts and some open questions," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 626-633.
    19. Bessen, James, 2008. "The value of U.S. patents by owner and patent characteristics," Research Policy, Elsevier, vol. 37(5), pages 932-945, June.
    20. Dirk Czarnitzki & Katrin Hussinger & Cédric Schneider, 2009. "Why Challenge the Ivory Tower? New Evidence on the Basicness of Academic Patents," Kyklos, Wiley Blackwell, vol. 62(4), pages 488-499, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jsusta:v:10:y:2018:i:9:p:3143-:d:167486. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.